9,99 €
9,99 €
inkl. MwSt.
Sofort per Download lieferbar
payback
0 °P sammeln
9,99 €
9,99 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
0 °P sammeln
Als Download kaufen
9,99 €
inkl. MwSt.
Sofort per Download lieferbar
payback
0 °P sammeln
Jetzt verschenken
9,99 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
0 °P sammeln
  • Format: ePub

The body's healing response to injury or infection is localized inflammation and it is normal. However, when inflammation moves beyond the local, it becomes abnormal. New research is showing that abnormal inflammation may be linked to a variety of diseases and conditions, including heart disease, cancer, asthma, diabetes, and arthritis among others. Researchers are suggesting that diet can reverse this inflammation and the conditions and diseases caused by it.
New to this edition:
- New testing including C-Reactive Protein (CRP)
- Results of new research studies, including information
…mehr

  • Geräte: eReader
  • mit Kopierschutz
  • eBook Hilfe
  • Größe: 1.94MB
Produktbeschreibung
The body's healing response to injury or infection is localized inflammation and it is normal. However, when inflammation moves beyond the local, it becomes abnormal. New research is showing that abnormal inflammation may be linked to a variety of diseases and conditions, including heart disease, cancer, asthma, diabetes, and arthritis among others. Researchers are suggesting that diet can reverse this inflammation and the conditions and diseases caused by it.

New to this edition:

- New testing including C-Reactive Protein (CRP)
- Results of new research studies, including information against omega 3
- New healthy eating plans and foods
- New recipes
- Stress reduction to reduce inflammation


Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, EW, E, FIN, F, GR, HR, H, IRL, I, L, LR, M, NL, PL, P, R, SLO, SK ausgeliefert werden.

Autorenporträt
Christopher P. Cannon, MD is an Associate Professor of Medicine at Harvard Medical School in the Cardiovascular Division at Brigham and Women's Hospital in Boston. He is a senior investigator of the Thrombolysis in Myocardial Infarction (TIMI) Study Group, and over the past two decades has been the principal investigator for more than 10 international clinical trials in the area of heart attacks and prevention. Recent trials include PROVE IT-TIMI 22, which showed that "lower is better" for cholesterol and changed international guidelines, and CLARITY-TIMI 28 which showed that giving heart attack patients clopidogrel (Plavix) can prevent future heart attacks. Author home: Boston, MA.